Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 5 389 M
EBIT 2015 1 502 M
Net income 2015 426 M
Debt 2015 4 610 M
Yield 2015 0,28%
Sales 2016 6 251 M
EBIT 2016 1 814 M
Net income 2016 917 M
Debt 2016 3 642 M
Yield 2016 0,31%
P/E ratio 2015 81,89
P/E ratio 2016 22,50
EV / Sales 2015 4,59x
EV / Sales 2016 3,80x
Capitalization 20 124 M
More Financials
Company
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences.The CHC segment includes... 
Sector
Pharmaceuticals
Calendar
08/03Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
02/10 Mylan to buy Swedish drugmaker Meda in $7.2 billion deal
02/10DJMylan Reaches $7.2 Billion Deal For Sweden's Meda
01/29 Valeant defends price hikes after Clinton remarks; shares jump
01/21 PERRIGO : Initiates Voluntary Product Recall In The U.S. Of Children's Guaifenes..
01/20 PERRIGO : Other Events (form 8-K)
01/20DJGoldman Makes Debt Financing A Priority
01/19DJGoldman Turns to Loans, Bond Underwriting
01/17 PERRIGO : $13.79 Million Federal Contract Awarded to Perrigo
More news
Sector news : Pharmaceuticals - NEC
01:33a GLAXOSMITHKLINE : *ubs raises glaxosmithkline price target to 1420 pence - 'neut..
01:16a NOVARTIS : Sandoz advances its biosimilars program with EMA acceptance of regula..
01:11a HIKMA PHARMACEUTICALS : plummets on lower offer for US drug business
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions